biote Corp. BTMD
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- -57.31%
- 1 year
- -60.07%
- Open
- 1.17
- Prev close
- 1.17
- Mkt cap
- 37.63M
- Vol
- 65.59K
- Avg vol
- 204.64K
- EPS
- 0.14
- P/E
- 7.93
- Div yield
- 0.00%
More statistics
- Low
- 1.11
- High
- 1.20
- Forward P/E
- 9.98
- Beta
- 0.00
- Short ratio
- 3.73
- Inst. own
- 64.60%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 8, 2024
- 50-d avg
- 5.88
- 200-d avg
- 6.21
- 1y target
- 9.95
2Y chart
Events in this range
- Nov 12, 2024Earnings: 0.33; estimate 0.09; surprise 266.67%
- Dec 16, 2024Rating: Craig-Hallum · — → Buy
Signals (77)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 13, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 8, 2026 | 3 weeks ago |
| MACD: Sell Signal | Oct 1, 2026 | 1 month ago |
| RSI: Oversold | Oct 1, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 30, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 24, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 18, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 11, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 25, 2026 | 2 months ago |
| RSI: Oversold | Aug 17, 2026 | 2 months ago |
| RSI: Oversold | Aug 12, 2026 | 2 months ago |
| RSI: Oversold | Aug 7, 2026 | 2 months ago |
| SMA: Bearish | Aug 6, 2026 | 2 months ago |
| SMA: Bearish | Aug 6, 2026 | 2 months ago |
| SMA: Bullish | Jul 30, 2026 | 3 months ago |
| SMA: Bearish | Jul 29, 2026 | 3 months ago |
| SMA: Bearish | Jul 28, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 27, 2026 | 3 months ago |
| SMA: Bullish | Jul 24, 2026 | 3 months ago |
| SMA: Bearish | Jul 23, 2026 | 3 months ago |
| SMA: Bullish | Jul 16, 2026 | 3 months ago |
| SMA: Bearish | Jul 14, 2026 | 3 months ago |
| SMA: Bullish | Jul 10, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 7, 2026 | 3 months ago |
| SMA: Bullish | Jul 2, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 18, 2026 | 4 months ago |
| SMA: Bearish | Jun 15, 2026 | 4 months ago |
| SMA: Bullish | Jun 11, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 3, 2026 | 5 months ago |
| MACD: Sell Signal | May 5, 2026 | 6 months ago |
| RSI: Overbought | Apr 17, 2026 | 6 months ago |
| SMA: Bullish | Apr 14, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 1, 2026 | 7 months ago |
| RSI: Oversold | Mar 26, 2026 | 7 months ago |
| RSI: Oversold | Mar 9, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 6, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 4, 2026 | 9 months ago |
| RSI: Oversold | Jan 28, 2026 | 9 months ago |
| MACD: Sell Signal | Dec 30, 2025 | 10 months ago |
| SMA: Bearish | Dec 26, 2025 | 10 months ago |
| SMA: Bullish | Dec 24, 2025 | 10 months ago |
| SMA: Bearish | Dec 23, 2025 | 10 months ago |
| SMA: Bullish | Dec 18, 2025 | 10 months ago |
| SMA: Bearish | Dec 12, 2025 | 10 months ago |
| SMA: Bullish | Dec 10, 2025 | 10 months ago |
| MACD: Buy Signal | Nov 25, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 10, 2025 | 11 months ago |
| MACD: Buy Signal | Oct 31, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 29, 2025 | 1 year ago |
| SMA: Bearish | Oct 23, 2025 | 1 year ago |
| SMA: Bullish | Oct 22, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 15, 2025 | 1 year ago |
| RSI: Oversold | Oct 10, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 22, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 25, 2025 | 1 year ago |
| RSI: Oversold | Aug 7, 2025 | 1 year ago |
| SMA: Bearish | Aug 6, 2025 | 1 year ago |
| SMA: Bullish | Aug 4, 2025 | 1 year ago |
| SMA: Bearish | Aug 1, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 1, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 25, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 7, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 9, 2025 | 1 year ago |
| SMA: Bullish | Jun 5, 2025 | 1 year ago |
| SMA: Bearish | May 28, 2025 | 1 year ago |
| MACD: Sell Signal | May 28, 2025 | 1 year ago |
| SMA: Bullish | May 8, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 9, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 28, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 18, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 13, 2025 | 1 year ago |
| RSI: Oversold | Mar 13, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 7, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 25, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 24, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 21, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 19, 2025 | 1 year ago |
Key statistics
- Market cap
- 305.42M
- Enterprise value
- 287.07M
- Trailing P/E
- 19.30
- Forward P/E
- 9.98
- PEG ratio
- 0.00
- Price / sales
- 1.58
- Price / book
- 0.00
- EPS (TTM)
- 0.30
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 3.72%
- Revenue (TTM)
- 193.06M
- Revenue growth
- 12.80%
- Free cash flow
- 37.61M
- Total cash
- 38.23M
- Total debt
- 122.31M
- Return on equity
- 0.00%
- Shares outstanding
- 31.11M
- Short % of float
- 3.21%
- 50-day average
- 5.88
- 200-day average
- 6.21
Analyst view
Consensus: strong buy
- Target (low)
- 8.00
- Target (mean)
- 9.95
- Target (high)
- 12.00
- Strong buy1
- Buy5
- Hold0
- Sell0
- Strong sell0
Next earnings
Aug 8, 2024
Expected Aug 8, 2024. Consensus EPS estimate 0.17.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 12, 2024 | Sep 1, 2024 | 0.09 | 0.33 | +0.24 | +266.67% |
| Aug 8, 2024 | Jun 1, 2024 | 0.09 | 0.14 | +0.05 | +55.56% |
| Aug 8, 2024 | Jun 1, 2024 | 0.09 | — | — | — |
| May 7, 2024 | Mar 1, 2024 | 0.05 | 0.23 | +0.18 | +360.00% |
| May 7, 2024 | Mar 1, 2024 | 0.05 | — | — | — |
| Mar 12, 2024 | Dec 1, 2023 | 0.08 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 16, 2024 | Craig-Hallum | init | — | Buy |
| Mar 13, 2024 | Roth MKM | reit | Buy | Buy |
| Feb 20, 2024 | B. Riley Securities | init | — | Buy |
| Feb 1, 2024 | Jefferies | init | — | Buy |
| Jan 18, 2024 | Truist Securities | main | Buy | Buy |
| Jan 18, 2024 | Roth MKM | main | Buy | Buy |
About biote Corp.
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support. It also sells dietary supplements under the Biote brand; and sterile pellet insertion kits that is used with hormone optimization therapies for male and female. The company was founded in 2012 and is headquartered in Irving, Texas.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- United States
- Website
- biote.com
News
- Head-To-Head Survey: The Pennant Group (NASDAQ:PNTG) vs. biote (NASDAQ:BTMD)
- Biote Schedules Third Quarter 2026 Financial Results Release and Conference Call
- biote (NASDAQ:BTMD) and Elevance Health (NYSE:ELV) Head to Head Review
- 12 Health Care Stocks Moving In Wednesday's After-Market Session
- B. Riley Securities Maintains Neutral on Biote, Lowers Price Target to $1.5
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- biote Corp. (BTMD) Q2 2026 Earnings Call Transcript
- biote Corp. (BTMD) Reports Break-Even Earnings for Q2
- biote Q2 Earnings Call Highlights
- 12 Health Care Stocks Moving In Wednesday's After-Market Session
Your note
Sign in to keep a note on BTMD — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BEER MARC D | Director | Sale | Jan 8, 2023 | 0 |
| CONE STEPHEN MARK | Director | Conversion of Exercise of derivative security | Jun 29, 2023 | 122,725 |
| CONLON MARY ELIZABETH | General Counsel | Sale | Jul 4, 2023 | 140,393 |
| HEYER ANDREW R | Director | Purchase | Jan 8, 2023 | 0 |
| JACOBY DANA LYNN | Director | Conversion of Exercise of derivative security | May 20, 2024 | 50,970 |
| KAMDAR SAMAR JAGAT | Chief Financial Officer | Purchase | Jan 8, 2023 | 13,000 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| 325 Capital Llc | 14.32% | 4,548,127 | 26.33M | Sep 29, 2024 |
| Bandera Partners LLC | 7.67% | 2,435,635 | 14.10M | Sep 29, 2024 |
| Blackrock Inc. | 5.44% | 1,725,875 | 9.99M | Sep 29, 2024 |
| Vanguard Group Inc | 4.47% | 1,417,793 | 8.21M | Sep 29, 2024 |
| Wasatch Advisors LP | 4.39% | 1,392,809 | 8.06M | Sep 29, 2024 |
| Dimensional Fund Advisors LP | 2.14% | 678,459 | 3.93M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.70% | 856,603 | 4.96M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 2.12% | 673,534 | 3.90M | Oct 30, 2024 |
| Wasatch Micro-Cap Value Fund | 1.93% | 613,010 | 3.55M | Sep 29, 2024 |
| RBB Fund Inc.- Boston Partners Small Cap Value Fd II | 1.56% | 493,862 | 2.86M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 1.08% | 342,071 | 1.98M | Sep 29, 2024 |
| Fidelity Small Cap Index Fund | 0.85% | 270,540 | 1.57M | Aug 30, 2024 |